Disease-related mortality within the first year after subtotal esophagectomy for cancer

Annals of Surgical Oncology

Volumn 18, Issue 4, 2011, Pages 1139-1144

  Pines, Guy ^a   Klein, Yoram ^a   Buyeviz, Victor ^a   Idelevich, Efraim ^b   Kashtan, Hanoch ^a  

^a KAPLAN MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER SURVIVAL; CONTINUOUS INFUSION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; PERIOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SUBTOTAL ESOPHAGUS RESECTION; SURVIVAL TIME; TREATMENT RESPONSE;

ADENOCARCINOMA; AGED; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79955840455     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1386-4     Document Type: Article

References (32)

1. Muller JM et al. Surgical therapy of oesophageal carcinoma. Br J Surg. 1990;77(8):845-57. (Pubitemid 20249685)
2. Sabanathan S, et al. Results of surgical treatment of oesophageal cancer. J R Coll Surg Edinb. 1996;41(5):295-301. (Pubitemid 26340986)
3. Morstyn G, et al. Improved survival in esophageal cancer in the period 1978 to 1983. J Clin Oncol. 1986;4(7):1062-7. (Pubitemid 16059734)
4. Wu PC, Posner MC. The role of surgery in the management of oesophageal cancer. Lancet Oncol. 2003;4(8):481-8. (Pubitemid 37009956)
5. Pines G, et al. The use of circular stapler for cervical esophagogastric anastomosis after esophagectomy: surgical technique and early postoperative outcome. Dis Esophagus. 2009;22(3):274-8.
6. Bedenne L, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007;25(10):1160-8. (Pubitemid 46640561)
7. Coia LR, et al. Long-term results of infusional 5-FU, mitomycin- C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys. 1991;20(1):29-36.
8. Leichman L, et al. Nonoperative therapy for squamous-cell cancer of the esophagus. J Clin Oncol. 1987;5(3):365-70. (Pubitemid 17045457)
9. Seitz JF, et al. Inoperable nonmetastatic squamous cell carcinoma of the esophagus managed by concomitant chemotherapy (5-fluorouracil and cisplatin) and radiation therapy. Cancer. 1990;66(2):214-9. (Pubitemid 20205898)
10. Sobon LH, Wittekind, C, editors. UICC TNM classification of malignant tumors. 6th ed. New York: Wiley; 2002.
11. Eisenhauer EA, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228-47.
12. Idelevich E, et al. Overall survival with cisplatin and 5-fluorouracil neoadjuvant treatment in patients with esophageal cancer: single-center experience. Onkologie. 2008;31(12):673-7.
13. Allum WH, et al. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol. 2009;27(30):5062-7.
14. Stahl M, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol. 2005;23(10):2310-7. (Pubitemid 46218723)
15. Wijnhoven BP, et al. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg. 2007;245(5):717-25. (Pubitemid 46684101)
16. Thompson SK, et al. Improving the accuracy of TNM staging in esophageal cancer: a pathological review of resected specimens. Ann Surg Oncol. 2008;15(12):3447-58.
17. Rice TW, et al. Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals. Cancer. 2010;116(16): 3763-73.
18. Peyre CG, et al. Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes. Ann Surg. 2008;248(6):979-85.
19. Nitti D, et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol. 2003;10(9):1077-85. (Pubitemid 40486832)
20. Peng J, et al. Prognostic significance of the metastatic lymph node ratio in node-positive rectal cancer. Ann Surg Oncol. 2008;15(11):3118-23.
21. Bando E, et al. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol. 2002;9(8):775-84.
22. Nigro JJ, et al. Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg. 1999;117(5):960-8. (Pubitemid 29210780)
23. Darling G. The role of lymphadenectomy in esophageal cancer. J Surg Oncol. 2009;99(4):189-93.
24. Mariette C, et al. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg. 2008;247(2):365-71. (Pubitemid 351156783)
25. Dexter SP, et al. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut. 2001;48(5):667-70. (Pubitemid 32378588)
26. Scheepers JJ, et al. Influence of circumferential resection margin on prognosis in distal esophageal and gastroesophageal cancer approached through the transhiatal route. Dis Esophagus. 2009;22(1):42-8.
27. Barbour AP, et al. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Ann Surg. 2007;246(1):1-8. (Pubitemid 47012198)
28. Griffiths EA, et al. The prognostic value of circumferential resection margin involvement in oesophageal malignancy. Eur J Surg Oncol. 2006;32(4):413-9.
29. Machlenkin S, Melzer E, Idelevich E, Ziv-Sokolovsky N, Klein Y, Kashtan H. Endoscopic ultrasound: doubtful accuracy for restaging of esophageal cancer after preoperative chemotherapy. Isr Med Assoc J. 2009;11(3):166-9.
30. Krasna MJ, et al. Combined thoracoscopic/laparoscopic staging of esophageal cancer. J Thorac Cardiovasc Surg. 1996;111(4):800-6; discussion 806-7.
31. Krasna MJ, et al. CALGB 9380: a prospective trial of the feasibility of thoracoscopy/laparoscopy in staging esophageal cancer. Ann Thorac Surg. 2001;71(4):1073-9. (Pubitemid 32328648)
32. Krasna MJ, et al. Thoracoscopy/laparoscopy in the staging of esophageal cancer: Maryland experience. Surg Laparosc Endosc Percutan Tech. 2002;12(4):213-8. (Pubitemid 36401733)